Boston, Massachusetts-based Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on therapeutics for neurodegenerative diseases, has announced that it is "exploring strategic alternatives with the goal of enhancing shareholder value."
Translation: the company is in financial difficulty and is for sale. As part of a cost-containment initiative, the company is restructuring and anticipates eliminating approximately 60% of its workforce with the separations being completed by April 2022.
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life or promises for a bright future. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere. No one is guaranteed to wake up tomorrow and still have a job by evening. Are you now wondering, Am I Next?